Spots Global Cancer Trial Database for solid cancer
Every month we try and update this database with for solid cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT06161025 | Solid Cancer | R-DXd Gemcitabine Paclitaxel Topotecan PLD | 18 Years - | Daiichi Sankyo | |
| Hepatic Arterial Infusion (HAI) of Abraxane | NCT00732836 | Liver Cancer Advanced Cancer... Solid Tumors | HAI Abraxane Hepatic Artery ... IV Abraxane | 18 Years - | M.D. Anderson Cancer Center | |
| Immunological Profile of Solid Tumors Sample | NCT03311100 | Solid Cancer | immunohistochem... | 18 Years - | Assistance Publique Hopitaux De Marseille | |
| Hypofractionated Brain Radiationcavity | NCT03561896 | Brain Metastase... Cancer Brain | IGRT SRS | 18 Years - | Oncology Institute of Southern Switzerland | |
| CIRculating CANcer MAster-Protocol | NCT05089747 | Adult With Soli... | Blood sampling ... | 18 Years - | Hospices Civils de Lyon | |
| Cell Phone Application to Help Adolescents and Young Adults in Their Therapeutic and Educational Journey | NCT05617131 | Cancer | 15 Years - 25 Years | University Hospital, Strasbourg, France | ||
| Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1 | NCT03721679 | Solid Cancer | Poly-ICLC combi... | 18 Years - | Oncovir, Inc. | |
| Metastatic Spinal Bone Marrow Response to Radiation Therapy Using T1 Weighted Dynamic Contrast-Enhanced Perfusion | NCT02376127 | Solid Cancer Metastatic Spin... | Dynamic contras... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Clinical Study of Regorafenib in Participants Who Have Been Treated in Previous Bayer-sponsored Regorafenib Studies That Have Been Completed | NCT03890731 | Solid Cancer | BAY73-4506 (Reg... | 18 Years - | Bayer | |
| Elderly CAncer Patient | NCT02884375 | Hematologic Mal... Solid Cancer | Extensive GA | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
| Hepatic Arterial Infusion (HAI) of Abraxane | NCT00732836 | Liver Cancer Advanced Cancer... Solid Tumors | HAI Abraxane Hepatic Artery ... IV Abraxane | 18 Years - | M.D. Anderson Cancer Center | |
| Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies | NCT04552288 | Solid Tumor Solid Carcinoma Solid Tumor, Ad... Hematologic Mal... | Benralizumab | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT06161025 | Solid Cancer | R-DXd Gemcitabine Paclitaxel Topotecan PLD | 18 Years - | Daiichi Sankyo | |
| Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers | NCT05302037 | Cancer Malignancy Refractory Canc... Relapsed Cancer | Allogeneic NKG2... | 21 Years - | CytoMed Therapeutics Pte Ltd | |
| Elderly CAncer Patient | NCT02884375 | Hematologic Mal... Solid Cancer | Extensive GA | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
| Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes) | NCT02959905 | Solid Cancer | TSA-CTL Cyclophosphamid... Fludarabine Cyclophosphamid... | 18 Years - 70 Years | BGI, China | |
| Hypofractionated Brain Radiationcavity | NCT03561896 | Brain Metastase... Cancer Brain | IGRT SRS | 18 Years - | Oncology Institute of Southern Switzerland | |
| Metaxa Hospital THromboprophylaxis Program in Oncological & Surgical Patients | NCT04248348 | Thrombosis Solid Cancer | Low Molecular W... | 18 Years - | Metaxa Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
